FORBES-TATE for EMERGENT BIOSOLUTIONS

Disaster Planning/Emergencies DIS

Issues related to H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Issues related to FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021; Issues related to S. 4231 - Preparing for the Next Pandemic Act; Issues related to S. 1624 - HEALS Act; Issues related to H.R. 2466 - The State Opioid Response Grant Authorization Act; Issues related to H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020; Issues related to H.R. 133 Consolidated Appropriations Act, 2021.

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Substance Abuse & Mental Health Services Administration (SAMHSA); SENATE; Office of Natl Drug Control Policy (NDCP); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Office of Management & Budget (OMB)

Bills named: H.R. 2466 (116th), S. 4231 (116th), H.R. 748 (116th), H.R. 7574 (116th), H.R. 133 (116th), S. 1624 (116th)

Health Issues HCR

Issues related to H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Issues related to FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021; Issues related to H.R. 133 Consolidated Appropriations Act, 2021.

Contacted: Justice, Dept of (DOJ); Substance Abuse & Mental Health Services Administration (SAMHSA); Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Office of Natl Drug Control Policy (NDCP); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 133 (116th), H.R. 748 (116th)

Budget/Appropriations BUD

Issues related to H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Issues related to FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021; Issues related to H.R. 925 - The Heroes Act; Issues related to S. 4231 - Preparing for the Next Pandemic Act; Issues related to S. 1624 - HEALS Act; Issues related to H.R. 2466 - The State Opioid Response Grant Authorization Act; Issues related to H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020; Issues related to H.R. 133 Consolidated Appropriations Act, 2021.

Contacted: Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); SENATE; Office of Natl Drug Control Policy (NDCP); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC); Substance Abuse & Mental Health Services Administration (SAMHSA)

Bills named: H.R. 748 (116th), H.R. 2466 (116th), H.R. 7574 (116th), H.R. 133 (116th), H.R. 925 (116th), S. 4231 (116th), S. 1624 (116th)

Homeland Security HOM

Issues related to H.R. 748 - CARES Act (Public Law 116-136), and FY 2021 Appropriations related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; NDAA, provisions related to biological and chemical defense; Issues related to Priority Review Voucher programs; Issues regarding opioid and heroin addiction legislation, naloxone access, co-prescribing, and opioid prescribing guidelines; Emergency Support for Substance Use Disorders Act/Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder; Issues related to FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government; Issues related to State Opioid Response Grants funding for FY 2021; Issues related to S. 4231 - Preparing for the Next Pandemic Act; Issues related to S. 1624 - HEALS Act; Issues related to H.R. 2466 - The State Opioid Response Grant Authorization Act; Issues related to H.R. 7574 - Strengthening Americas Strategic National Stockpile Act of 2020; Issues related to H.R. 133 Consolidated Appropriations Act, 2021.

Contacted: Office of Management & Budget (OMB); SENATE; Centers For Disease Control & Prevention (CDC); Substance Abuse & Mental Health Services Administration (SAMHSA); Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP)

Bills named: H.R. 748 (116th), S. 1624 (116th), H.R. 133 (116th), H.R. 7574 (116th), H.R. 2466 (116th), S. 4231 (116th)